415 Capital
VC · Munich (Germany)
Sign up free to access full profile and submit your pitch.
About
415 Capital Management GmbH & Co is a venture capital firm that invests in clinical through commercial stage med tech companies. The firm does not invest in biotech/pharma, healthcare services and wellness products sectors. The firm primarily invest in innovative medical device technologies addressing cardio and neurovascular disease. They typically invest in med tech, medical robotics, structural heart disease, heart failure, aortic and peripheral vascular disease, neurovascular disease/stroke, hypertension, electrophysiology, neuromodulation for chronic diseases (e.g. cardiovascular, sleep apnea), medical imaging, patient monitoring sectors. The firm prefers to invest in the companies based in Europe, North America, and Israel. The firm makes equity investments between €5 million ($5.46 million) and €15 million ($16.40 million) per company. 415 Capital Management GmbH & Co was founded in 2018 and is based in Munich, Germany.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of 415 Capital
Other investors that have backed the same portfolio companies as 415 Capital. Expand any entry to see the shared portfolio companies.
- 3 shared
Shared portfolio companies
- 3 shared
Shared portfolio companies
- Aktiia SA
- CorFlow Therapeutics AG
- TRiCares SAS
- 2 shared
Shared portfolio companies
- 1 shared
Shared portfolio companies
- TRiCares SAS
- 1 shared
Shared portfolio companies
- TRiCares SAS
- 1 shared
Shared portfolio companies
- TRiCares SAS
- 1 shared
Shared portfolio companies
- TRiCares SAS
- 1 shared
Shared portfolio companies
- 1 shared
Shared portfolio companies
- 1 shared
Shared portfolio companies
- TRiCares SAS
.png)
